PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
E Ghigo Selected Research
Obesity
10/2004
Ghrelin: a link between eating disorders, obesity and reproduction.
11/2003
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity.
02/2003
Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity.
06/2002
Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity.
04/2002
Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity.
09/2001
Control and function of the GH-IGF-I axis in obesity.
08/2001
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
03/2001
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
01/2001
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
10/2000
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity.
06/2000
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors.
Articles by Research Topic
Disease
11
Obesity
10/2004 - 06/2000
6
Anorexia Nervosa
05/2004 - 06/2000
5
Acromegaly
09/2007 - 01/2002
3
Neoplasms (Cancer)
10/2006 - 10/2001
3
Hypopituitarism (Sheehan's Syndrome)
06/2004 - 04/2001
3
Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
02/2001 - 02/2000
2
Cushing Syndrome
02/2003 - 03/2001
2
Migraine Disorders (Migraine)
05/2001 - 05/2000
2
Q Fever (Fever, Q)
08/2000 - 01/2000
2
Endocarditis
08/2000 - 01/2000
1
Primary Hyperparathyroidism
08/2008
1
Fatigue
01/2008
1
Small Cell Carcinoma
10/2006
1
Lung Neoplasms (Lung Cancer)
10/2006
1
Prolactinoma (Prolactinomas)
04/2006
1
Bulimia Nervosa (Binge Eating Disorder)
07/2005
1
Eating Disorders (Eating Disorder)
10/2004
1
Brain Injuries (Brain Injury)
06/2004
1
Syndrome
02/2004
1
Starvation
12/2003
1
Body Weight (Weight, Body)
04/2003
1
Hyperandrogenism
03/2003
1
Obstructive Sleep Apnea
11/2002
1
Thyroid Neoplasms (Thyroid Cancer)
04/2002
1
Cardiomyopathies (Cardiomyopathy)
03/2002
1
Wounds and Injuries (Trauma)
03/2002
1
Left Ventricular Dysfunction
03/2002
1
Hyperglycemia
10/2001
1
Carcinoma (Carcinomatosis)
04/2001
1
Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
12/2000
1
Necrosis
08/2000
1
Addison Disease (Addison's Disease)
07/2000
Drug/Important Bio-Agent (IBA)
14
Insulin-Like Growth Factor I (IGF-1)
IBA
12/2004 - 06/2000
10
Ghrelin
IBA
08/2008 - 04/2001
9
Growth Hormone (Somatotropin)
IBA
04/2006 - 05/2000
4
Insulin (Novolin)
FDA Link
04/2006 - 12/2000
4
Adrenocorticotropic Hormone (ACTH)
FDA Link
05/2004 - 07/2000
3
Hormones
IBA
04/2001 - 08/2000
2
Peptides
IBA
10/2006 - 02/2001
2
Sumatriptan (Imigran)
FDA Link
05/2001 - 05/2000
2
Arginine (L-Arginine)
FDA Link
04/2001 - 02/2000
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2008
1
pegvisomant
FDA Link
Generic
09/2007
1
cortistatin
IBA
10/2006
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
04/2006
1
Prolactin
IBA
04/2006
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2003
1
Cholinesterase Inhibitors (Anticholinesterases)
IBA
06/2003
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
06/2003
1
Gonadotropins
IBA
03/2003
1
Goserelin (Zoladex)
FDA Link
03/2003
1
Leptin
IBA
02/2003
1
Glucose (Dextrose)
FDA Link
Generic
02/2003
1
Glucagon (Glukagon)
FDA Link
06/2002
1
cortistatin 14
IBA
04/2002
1
hexarelin
IBA
03/2002
1
Cosyntropin (Cortrosyn)
FDA Link
10/2000
1
Insulin-Like Growth Factor Binding Protein 3
IBA
09/2000
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
08/2000
1
Nonesterified Fatty Acids (NEFA)
IBA
06/2000
1
acipimox
IBA
06/2000
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2000